Today: 9 June 2026
Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results
20 January 2026
1 min read

Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

London, January 20, 2026, 08:47 GMT — Regular session

  • Unilever (ULVR.L) slipped roughly 0.7% early in London, trading near 4,733p
  • Berenberg sticks with its Buy rating on Unilever, maintaining a 5,600p target price
  • Investors are eyeing the Feb. 12 results for clues on volume and margins following the ice cream demerger

Unilever (ULVR.L) shares edged down 0.7% to 4,732.5 pence in early London trade Tuesday. The stock hovered in a tight range, between 4,727p and 4,753p, with about 97,000 shares changing hands. Year to date, the shares are down roughly 2.6%.

European stocks slipped once more, pressured by trade tensions after U.S. President Donald Trump renewed tariff threats against several European nations. By 0803 GMT, the pan-European STOXX 600 had dropped 0.7%, Reuters noted.

Unilever had no clear new driver during the session. The shares moved as usual—anchored as a major defensive consumer stock that tends to follow broader market swings when risk appetite fades.

A broker note brought a company-specific angle. On Monday, Berenberg analyst Fulvio Cazzol reaffirmed a Buy rating, maintaining a target price of 5,600 pence and describing the stock as “attractive.” MarketScreener

Investors are eyeing the calendar closely. Unilever is set to release its fourth-quarter and full-year 2025 results on Feb. 12, with a scheduled appearance at the CAGNY Conference on Feb. 17, according to its investor site.

In a pre-close note dated Jan. 8, Unilever projected 2025 underlying sales growth—excluding currency and M&A effects—between 3% and 5%. The company expects second-half underlying operating margin to hit at least 19.5%. Fourth-quarter underlying volume growth should match or exceed the third quarter’s 1.7%. It also said tariff impacts on profitability were limited and already factored into margin forecasts.

February’s report will be the first to show a full year of figures excluding ice cream, now classified as discontinued following the split. Unilever announced in December that its ice cream division, renamed The Magnum Ice Cream Company, was spun off on Dec. 6. New shares began trading Dec. 8, with a share consolidation happening the next day.

Investors are now digging deeper into the remaining mix, searching for signs that volume can keep climbing even as price gains slow. They’re also looking for evidence that margins stay strong while the group invests in brands and drives productivity savings. Cash flow and any hints on capital returns will draw just as much scrutiny.

February’s numbers will be a clear turning point. Falling short on volumes, weaker margin guidance, or currency headwinds could swiftly change the outlook—even for a company primarily recognized for soap, deodorant, and pantry staples.

For now, macro factors will likely keep dominating the tape. Traders are focused on whether tariff threats turn into actual policy starting Feb. 1 and how that impacts overall risk sentiment. Unilever’s key upcoming events are its Feb. 12 earnings and the CAGNY presentation on Feb. 17.

Stock Market Today

  • Wall Street Embraces 'MANGOS' AI Stock Acronym Ahead of IPOs
    June 9, 2026, 11:07 AM EDT. Wall Street traders are focusing on MANGOS, a new acronym representing key AI players Meta, Anthropic, Nvidia, Google, OpenAI, and SpaceX, signaling growing interest in the artificial intelligence sector. The term, which evolved from a semiconductor stock acronym, reflects the increasing market attention to AI-driven companies. Another acronym, TANGOES, adds Tesla to the mix amid speculation of a future SpaceX-Tesla merger. Analysts note upcoming IPOs for SpaceX, Anthropic, and OpenAI, sometimes grouped under the term AI3. These acronyms highlight Wall Street's strategic positioning ahead of major AI developments and public listings.

Latest articles

Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

9 June 2026
Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
Reddit Shares Pop After Wall Street Sees the Right Ad Signal

Reddit Shares Pop After Wall Street Sees the Right Ad Signal

9 June 2026
Reddit shares surged 6.6% to $182.44 after Cleveland Research and Piper Sandler cited stronger ad demand and raised revenue forecasts, with Cleveland noting 45% of advertisers beat ROI targets in Q2 and Reddit taking ad share from rivals, but risks remain around user growth, AI search traffic, and high valuation.
Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
OpenAI CFO Sarah Friar lifts lid on $20B revenue run rate as 2026 shifts to “practical adoption”
Previous Story

OpenAI CFO Sarah Friar lifts lid on $20B revenue run rate as 2026 shifts to “practical adoption”

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
Next Story

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Go toTop